toyocamycin has been researched along with adenosine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barbeau, O; Burke, R; Cheeseman, MD; Collins, I; Dobson, S; Jeganathan, F; Jones, AM; Jones, K; Kadi, N; Rowlands, M; van Montfort, RL; Westwood, IM; Workman, P | 1 |
| Bayle, ED; Fish, PV; Li, F; Schapira, M; Spurr, SS; Tempel, W; Vedadi, M; Yu, W | 1 |
| Hadjiolov, AA; Stateva, LI; Venkov, PV | 1 |
| BOHME, R; Fouquet, H; Sauer, HW; Wick, R | 1 |
| Granick, D | 2 |
| Hamada, M; Imoto, M; Nishioka, H; Sawa, T; Shimura, N; Umezawa, K | 1 |
| Hargrave, PA; Kahn, N; Palczewski, K | 1 |
| Gupta, RS; Mehta, KD | 2 |
| Cha, S; el Kouni, MH; Messier, NJ | 1 |
| Franze-Fernández, MT; Iapalucci-Espinoza, S; Medrano, EE; Perrone-Bizzozero, N | 1 |
| Bowersox, JC; Sorgente, N | 1 |
| Gupta, RS | 1 |
| Baba, T; D'Amato, RJ; Gray, JT; Lee, JS; Magnier, M; Mulligan, RC; Svendsen, J; Yen, L | 1 |
| An, H; Ding, Y; Girardet, JL; Hong, Z | 1 |
| Magnier, M; Mulligan, RC; Stockwell, BR; Weissleder, R; Yen, L | 1 |
| Azuma, M; Nerome, S; Ojima, Y; Tanibata, Y; Yokota, N | 1 |
18 other study(ies) available for toyocamycin and adenosine
| Article | Year |
|---|---|
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70.
Topics: Adenosine; Crystallography, X-Ray; Dose-Response Relationship, Drug; HSP70 Heat-Shock Proteins; Humans; Models, Molecular; Molecular Conformation; Structure-Activity Relationship | 2016 |
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.
Topics: Crystallography; Enzyme Inhibitors; Halogens; Histone-Lysine N-Methyltransferase; Methyltransferases; Nitriles; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
Toyocamycin inhibition of ribosomal ribonucleic acid processing in an osmotic-sensitive adenosine-utilizing Saccharomyces cerevisiae mutant.
Topics: Adenosine; Antibiotics, Antineoplastic; Kinetics; Mutation; Osmotic Pressure; Ribosomes; RNA, Ribosomal; Saccharomyces cerevisiae; Toyocamycin; Transcription, Genetic | 1977 |
Effects of cordycepin on RNA sythesis in Physarum polycephalum.
Topics: Adenosine; Dactinomycin; Deoxyadenosines; Kinetics; Myxomycetes; Physarum; RNA; Time Factors; Toyocamycin; Transcription, Genetic | 1975 |
Nucleolar necklaces in chick embryo fibroblast cells. II. Microscope observations of the effect of adenosine analogues on nucleolar necklace formation.
Topics: Adenosine; Amanitins; Animals; Arginine; Benzimidazoles; Cell Nucleolus; Cells, Cultured; Chick Embryo; Cycloheximide; Dactinomycin; Deoxyadenosines; Fibroblasts; Liver; Lucanthone; Microscopy, Phase-Contrast; Muscles; Toyocamycin; Tubercidin | 1975 |
Nucleolar necklaces in chick embryo fibroblast cells. I. Formation of necklaces by dichlororibobenzimidazole and other adenosine analogues that decrease RNA synthesis and degrade preribosomes.
Topics: Adenosine; Amanitins; Animals; Benzimidazoles; Cell Nucleolus; Cells, Cultured; Chick Embryo; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Liver; Methionine; Models, Biological; Ribosomes; RNA; RNA, Messenger; RNA, Ribosomal; RNA, Transfer; Toyocamycin; Tubercidin; Uridine | 1975 |
Inhibition of phosphatidylinositol kinase by toyocamycin.
Topics: 1-Phosphatidylinositol 4-Kinase; Adenosine; Benzaldehydes; Catechols; Flavonoids; Formycins; Molecular Structure; Phosphotransferases; Toyocamycin | 1990 |
Nucleoside inhibitors of rhodopsin kinase.
Topics: Adenosine; Animals; Binding Sites; Cattle; Eye Proteins; G-Protein-Coupled Receptor Kinase 1; Molecular Conformation; Nucleosides; Protein Kinase Inhibitors; Protein Kinases; Pyrimidine Nucleosides; Toyocamycin | 1990 |
Involvement of adenosine kinase in the phosphorylation of formycin B in CHO cells.
Topics: Adenosine; Adenosine Kinase; Amides; Animals; Antibiotics, Antineoplastic; Cell Line; Cricetinae; Drug Resistance; Female; Formycins; Methylthioinosine; Mutation; Ovary; Phosphorylation; Phosphotransferases; Pyrazoles; Ribonucleosides; Ribose; Toyocamycin; Tubercidin | 1985 |
Treatment of schistosomiasis by purine nucleoside analogues in combination with nucleoside transport inhibitors.
Topics: Adenosine; Animals; Biological Transport; Dilazep; Dipyridamole; Drug Therapy, Combination; Female; Mice; Purine Nucleosides; Ribonucleosides; Schistosoma mansoni; Schistosomiasis; Thioinosine; Thionucleotides; Toyocamycin; Tubercidin; Uracil | 1987 |
Transcription of ribosomal RNA is differentially controlled in resting and growing BALB/c 3T3 cells.
Topics: Adenosine; Animals; Blood; Cell Division; Cells, Cultured; Cycloheximide; Fibroblasts; Kinetics; Mice; Mice, Inbred BALB C; Pactamycin; RNA Polymerase I; RNA, Ribosomal; Toyocamycin; Transcription, Genetic; Uridine | 1985 |
Formycin B-resistant mutants of Chinese hamster ovary cells: novel genetic and biochemical phenotype affecting adenosine kinase.
Topics: Adenosine; Adenosine Kinase; Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Line; Cells, Cultured; Cricetinae; Drug Resistance; Formycins; Mutation; Phosphotransferases; Toyocamycin; Tubercidin | 1983 |
Fibronectin-induced protein carboxy-O-methylation in aortic endothelial cells.
Topics: Adenosine; Animals; Aorta; Cattle; Cells, Cultured; Chemotaxis; Endothelium; Fibronectins; Kinetics; Methylation; Protein Methyltransferases; Protein O-Methyltransferase; Proteins; S-Adenosylmethionine; Toyocamycin | 1984 |
Adenosine-AMP exchange activity is an integral part of the mammalian adenosine kinase.
Topics: Adenosine; Adenosine Kinase; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Arsenates; Cattle; CHO Cells; Cricetinae; Enzyme Inhibitors; Enzyme Stability; Kinetics; Liver; Magnesium; Mutation; Phosphates; Temperature; Toyocamycin; Tubercidin | 1996 |
Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.
Topics: Adenosine; Animals; Base Pairing; Base Sequence; Catalysis; Cell Line; Cell Line, Tumor; Cricetinae; Gene Expression Regulation; Genes, Reporter; Genetic Engineering; Genetic Vectors; Humans; Mice; Molecular Sequence Data; Oligonucleotides; Organ Specificity; RNA, Catalytic; RNA, Messenger; Toyocamycin | 2004 |
Synthesis of 2'-beta-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors.
Topics: Adenosine; Antiviral Agents; Hepacivirus; Pyrimidine Nucleosides; Replicon; Structure-Activity Relationship; Toyocamycin | 2005 |
Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.
Topics: Acridine Orange; Adenosine; Animals; Antibiotics, Antineoplastic; beta-Galactosidase; Cell Line; Cytidine; Drug Evaluation, Preclinical; Enzyme Inhibitors; Ethidium; Fluorouracil; Gene Expression Regulation, Enzymologic; Guanine; Humans; Mice; Mice, Nude; Molecular Structure; RNA, Catalytic; Toyocamycin; Tubercidin; Uridine | 2006 |
Concentrative Nucleoside Transporter, CNT, Results in Selective Toxicity of Toyocamycin against Candida albicans.
Topics: Adenosine; Candida albicans; Humans; Nucleoside Transport Proteins; Purine Nucleosides; Saccharomyces cerevisiae; Toyocamycin | 2022 |